Anti-sclerostin antibody and mechanical loading appear to influence metaphyseal bone independently in rats. - Wikidata - awgldk - TriplyDB

Anti-sclerostin antibody and mechanical loading appear to influence metaphyseal bone independently in rats.

Anti-sclerostin antibody and mechanical loading appear to influence metaphyseal bone independently in rats.

http://www.wikidata.org/entity/Q39921123

about

Targeting the Wnt pathways for therapies Sclerostin antibody inhibits skeletal deterioration due to reduced mechanical loading Rapidly growing Brtl/+ mouse model of osteogenesis imperfecta improves bone mass and strength with sclerostin antibody treatment Paradoxical response to mechanical unloading in bone loss, microarchitecture, and bone turnover markers Sclerostin inhibition: a novel therapeutic approach in the treatment of osteoporosis.Associations between body composition and bone density and structure in men and women across the adult age spectrum.Wnt signaling in bone formation and its therapeutic potential for bone diseases.Greater body mass independently predicts less radiographic progression on X-ray and MRI over 1-2 years.Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength.The Strategy to Prevent and Regress the Vascular Calcification in Dialysis Patients.Effects of anti-sclerostin antibody and running on bone remodeling and strength.Sclerostin monoclonal antibodies on bone metabolism and fracture healing.Early response of bone marrow osteoprogenitors to skeletal unloading and sclerostin antibody.

P2860

Q26821978-294CC4AF-5B8C-4F3C-9DE4-322B53F44247 Q33825376-58F7F000-391A-4DF5-814B-91D95329B82F Q34759279-E737DEC2-FFCF-4B4B-B8BC-DBFF18CD9C28 Q35197472-0FBE139A-98F2-49B1-BBC8-6D2EE9DAEB93 Q35694436-506ABCBC-7854-4EC3-B574-CACE79B4C4C0 Q36553559-EB12E6BF-69A0-4B9D-8F02-2D0CDB1DCE77 Q36638647-0C32CEC2-30F6-4575-9BD4-DE5EC75D87B8 Q36732733-89190B7A-87EA-40EF-8D37-EB8425769992 Q37119856-EA6E31DF-611C-474D-A6B2-E5034D8BD83E Q37670856-262FB927-E7B0-4B7A-BC29-AA4C90DA4140 Q37720443-05186DD5-6726-4160-B93D-44F72CC072BA Q38030984-932BEFFA-B81B-4E24-B681-0CC0B12C34D2 Q46900013-21114088-6AB7-4631-A14F-3750AA3FED89

P2860

Anti-sclerostin antibody and mechanical loading appear to influence metaphyseal bone independently in rats.

http://www.wikidata.org/entity/Q39921123

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Anti-sclerostin antibody and m ...... al bone independently in rats.

@en

Anti-sclerostin antibody and m ...... al bone independently in rats.

@nl

type

label

Anti-sclerostin antibody and m ...... al bone independently in rats.

@en

Anti-sclerostin antibody and m ...... al bone independently in rats.

@nl

prefLabel

Anti-sclerostin antibody and m ...... al bone independently in rats.

@en

Anti-sclerostin antibody and m ...... al bone independently in rats.

@nl

P1433

Q39921123-6F74930D-A472-4E06-9A3A-D5E964469235

P1476

Q39921123-F15E83A8-0808-4739-832C-911993DA85B2

P2093

Q39921123-119EA8D5-4DB4-47B4-95D6-0F3B85E7500D

Q39921123-315D4D17-3940-4B81-A147-8BA11DB6DF40

Q39921123-46F43FF1-62DC-4D8F-858A-C4A9FCE4A2EB

Q39921123-DCA73F5D-EB2C-43C7-9227-30DF370CF707

P2860

Q39921123-11207EB6-C3E6-4365-ACB0-568D3A3C1E7F

Q39921123-31DE7A49-8547-4290-8E8F-CBFD51E2C617

Q39921123-38118564-71AC-4698-A4DC-27FA4029FAC7

Q39921123-4D0D8A3E-D11F-4E19-B6E1-2AD951F65EB7

Q39921123-546809A4-6D57-4B1F-9B01-EF89DF269D70

Q39921123-6DE451E5-2E2B-408B-88C8-04AB0255692A

Q39921123-819C68E5-4CC7-4315-B40D-F9A2D623A997

Q39921123-9077D1B6-928C-4CD2-B7FA-D037DC054134

Q39921123-B3FE9593-3D40-48B8-A574-7BBB6A0E2B71

Q39921123-B6C7A881-A21C-4EF2-B850-8AD242424452

P304

Q39921123-683D3354-94DB-437F-960C-AB06130F7265

P31

Q39921123-A4285574-4648-41DE-8CEC-39E53A3BBC32

P356

Q39921123-21706AD6-1B5D-483A-8D58-35EB79553FFB

P433

Q39921123-AD983FD3-7397-46DB-AC60-4FD75FE42873

P478

Q39921123-B17BECFE-37A5-48DC-A36E-936D60E21AC2

P50

Q39921123-9C16A7F1-0A88-4849-BBA7-B3E8CF772E01

P577

Q39921123-B69636E3-2C7F-4025-9FD6-611C953BF45A

P5875

Q39921123-E8C21EA7-F583-4715-BC39-AD8E373E0A28

P698

Q39921123-525E70C9-CB70-4D0B-9213-770CF7EEA1FE

P921

Q39921123-6364A6C5-CD1E-4F9C-B338-9BD7B4365E5B

P932

Q39921123-BD1BF5DB-6254-4453-A949-FF81B11504D5

P356

17453674.2011.625539

P1433

Acta Orthopaedica

P1476

Anti-sclerostin antibody and m ...... al bone independently in rats.

@en

P2093

Fredrik Agholme

http://www.w3.org/2001/XMLSchema#string

Hua Zhu Ke

http://www.w3.org/2001/XMLSchema#string

Per Aspenberg

http://www.w3.org/2001/XMLSchema#string

Xiaodong Li

http://www.w3.org/2001/XMLSchema#string

P2860

Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)

Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein

Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing

Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling

Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin

Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation

Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength

Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis

Texture analysis of X-ray radiographs is a more reliable descriptor of bone loss than mineral content in a rat model of localized disuse induced by the Clostridium botulinum toxin.

Botox induced muscle paralysis rapidly degrades bone.

P304

628-632

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/17453674.2011.625539

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

82

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51818409

http://www.w3.org/2001/XMLSchema#string

P698

22103277

http://www.w3.org/2001/XMLSchema#string

P921

P932

3242963

http://www.w3.org/2001/XMLSchema#string